Gene: ARFGEF2
Official Full Name: ARF guanine nucleotide exchange factor 2provided by HGNC
Gene Summary: ADP-ribosylation factors (ARFs) play an important role in intracellular vesicular trafficking. The protein encoded by this gene is involved in the activation of ARFs by accelerating replacement of bound GDP with GTP and is involved in Golgi transport. It contains a Sec7 domain, which may be responsible for its guanine-nucleotide exchange activity and also brefeldin A inhibition. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO31719 | ARFGEF2 Knockout cell line (HeLa) | Human | ARFGEF2 | 1:3~1:6 | Negative | Online Inquiry |
KO31720 | ARFGEF2 Knockout cell line (HCT 116) | Human | ARFGEF2 | 1:2~1:4 | Negative | Online Inquiry |
KO31721 | ARFGEF2 Knockout cell line (HEK293) | Human | ARFGEF2 | 1:3~1:6 | Negative | Online Inquiry |
KO31722 | ARFGEF2 Knockout cell line (A549) | Human | ARFGEF2 | 1:3~1:4 | Negative | Online Inquiry |
ARFGEF2 Gene Knockout Cell Lines are specialized cellular models that have been genetically engineered to disrupt the ARFGEF2 gene, which plays a crucial role in membrane trafficking and cellular signal transduction. By creating cell lines devoid of this gene, researchers can systematically study the biological functions that ARFGEF2 influences, including its involvement in intracellular transport mechanisms, protein sorting, and cytoskeletal organization. These knockout cell lines serve as invaluable tools for elucidating the pathways through which ARFGEF2 operates, offering insights into cellular physiology and pathology.
The key function of ARFGEF2 is its role as a guanine nucleotide exchange factor (GEF) that activates ADP-ribosylation factors (ARFs), thus triggering vesicle formation and trafficking. When this gene is knocked out, researchers can observe the resultant changes in these trafficking pathways, leading to a deeper understanding of diseases where membrane transport is altered. Such knowledge is pivotal in developing therapies for conditions such as cancer, neurodegenerative diseases, and metabolic disorders.
In both research and clinical settings, ARFGEF2 gene knockout cell lines are indispensable for drug discovery, mechanism-of-action studies, and the development of targeted therapies. Unlike conventional cell lines that may retain functional redundancy, these knockout models provide clear and unambiguous data regarding the specific effects of ARFGEF2 absence.
The unique selling proposition of these cell lines lies in their robustness, reliability, and specificity. They allow for precise manipulation and observation of ARFGEF2-related processes without the confounding effects present in non-knockout lines. This precision empowers researchers and clinicians to draw concrete conclusions and enhance the accuracy of experimental outcomes.
By choosing our ARFGEF2 Gene Knockout Cell Lines, researchers are investing in a high-quality product backed by rigorous scientific validation. Our company specializes in developing state-of-the-art biological products that facilitate groundbreaking research, ensuring that our offerings are tailored for excellence in both laboratory and clinical environments, ultimately driving forward the frontiers of biomedical knowledge.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.